Your browser doesn't support javascript.
loading
Generation of mutant mice via the CRISPR/Cas9 system using FokI-dCas9.
Hara, Satoshi; Tamano, Moe; Yamashita, Satoshi; Kato, Tomoko; Saito, Takeshi; Sakuma, Tetsushi; Yamamoto, Takashi; Inui, Masafumi; Takada, Shuji.
Afiliação
  • Hara S; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Tamano M; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Yamashita S; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Kato T; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Saito T; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Sakuma T; Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima 739-8526, Japan.
  • Yamamoto T; Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima 739-8526, Japan.
  • Inui M; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
  • Takada S; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Sci Rep ; 5: 11221, 2015 Jun 09.
Article em En | MEDLINE | ID: mdl-26057433
ABSTRACT
Genome editing, which introduces mutations in genes of interest using artificial DNA nucleases such as the ZFN, TALEN, and CRISPR/Cas9 systems in living cells, is a useful tool for generating mutant animals. Although CRISPR/Cas9 provides advantages over the two other systems, such as an easier vector construction and high efficiency of genome editing, it raises concerns of off-target effects when single guide RNA (gRNA) is used. Recently, FokI-dCas9 (fCas9), a fusion protein comprised of the inactivated mutant form of Cas9 and the DNA nuclease domain of FokI, has been developed. It enables genome editing with reduced risks of off-target effects in mammalian cultured cell lines, as fCas9 requires gRNAs to bind opposite strands with an appropriate distance between them. Here, we demonstrated that fCas9 efficiently generates living mutant mice through microinjection of its mRNA and gRNAs into zygotes. A comparison of the relative efficiencies of genome editing using fCas9 and other modified Cas9s showed that these mutagenesis efficiencies are similar when the targets of two gRNAs are separated by an appropriate distance, suggesting that in addition to the ease of vector construction, fCas9 exhibit high efficiency in producing mutant mice and in reducing risks of off-target effects.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desoxirribonucleases de Sítio Específico do Tipo II / Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desoxirribonucleases de Sítio Específico do Tipo II / Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas Idioma: En Ano de publicação: 2015 Tipo de documento: Article